|
gptkbp:instanceOf
|
gptkb:drug
recombinant human follicle-stimulating hormone
|
|
gptkbp:administeredBy
|
subcutaneous injection
|
|
gptkbp:ATCCode
|
gptkb:G03GA06
|
|
gptkbp:CASNumber
|
155129-18-3
|
|
gptkbp:contraindication
|
pregnancy
primary ovarian failure
ovarian enlargement
uncontrolled thyroid or adrenal dysfunction
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
follitropin beta
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:macromoleculeType
|
gptkb:protein
|
|
gptkbp:marketedAs
|
gptkb:Follistim
gptkb:Puregon
|
|
gptkbp:pregnancyCategory
|
X (contraindicated)
|
|
gptkbp:producedBy
|
gptkb:Organon
gptkb:Merck_&_Co.
|
|
gptkbp:relatedTo
|
gptkb:follitropin_alfa
|
|
gptkbp:routeOfAdministration
|
subcutaneous
|
|
gptkbp:sideEffect
|
abdominal pain
headache
injection site reaction
ovarian hyperstimulation syndrome
|
|
gptkbp:subunit
|
alpha subunit
beta subunit
|
|
gptkbp:target
|
follicle-stimulating hormone receptor
|
|
gptkbp:UNII
|
P1J9J46203
|
|
gptkbp:usedFor
|
assisted reproductive technology
treatment of infertility
ovarian stimulation
|
|
gptkbp:bfsParent
|
gptkb:Fertavid
gptkb:Follistim
gptkb:Puregon
|
|
gptkbp:bfsLayer
|
6
|